icon
0%

Consolidated Edison ED - News Analyzed: 10,607 - Last Week: 100 - Last Month: 400

⇑ Consolidated Edison ED Makes Waves in the Bio-Tech Market with Strategic Investments and Bold Actions

Consolidated Edison ED Makes Waves in the Bio-Tech Market with Strategic Investments and Bold Actions

Ossiam, iSAM Funds UK Ltd, Entropy Technologies LP, Clean Energy Transition LLP, Russell Investments Group Ltd., and R Squared Ltd were among the firms increasing their holdings of Consolidated Edison (ED) shares. However, there were also insider sells with SVP Deneen Donnely reported to have offloaded 1,922 shares. Consolidated Edison recently secured a new $3.5 billion credit agreement, bolstering its financial flexibility.


Following the firm's recent share price momentum, its price target has been increased to $117 by some analysts predicting a rise. There has been considerable commentary on the recent earnings reports and performances, with Q4 results exceeding estimates. ED's aggressive capital spending plan and clean energy upgrades was notably mentioned.


Despite a proposed rate hike and pressure over grid strains, there's growing recognition of Consolidated Edison's commitment to reduce proposed rate hikes. Observers also highlighted how it's handling the equity raise to fund grid and clean energy upgrades, terming it influential to ED's investment story. The utility company outperformed its peers, potentially due to its influential institutional backing, strong value, and consistent payouts. The stock is seen as an attractive momentum and value play.

Consolidated Edison ED News Analytics from Thu, 07 Aug 2025 07:00:00 GMT to Sat, 14 Mar 2026 11:21:00 GMT - Rating 8 - Innovation 2 - Information 7 - Rumor -1

The email address you have entered is invalid.